spacer
home > events calendar > more about event
PHARMACEUTICAL INDUSTRY EVENTS CALENDAR

11th Annual Proteins & Antibodies Congress

Oxford Global - Proteins & Antibodies Congress

16-17 April 2018
Novotel London West Hotel, Hammersmith, London

Oxford Global Conferences are proud to present our esteemed 11th Annual Proteins & Antibodies Congress 2018, 16th 17th April 2018, London, UK. Over 450 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions

Over 50 case studies, presentations and panel discussions focused on the key issues in protein and antibody engineering & development, protein & antibody biotherapeutics as well as biotherapeutics manufacturing and chemistry.

Including 5 interactive streams:

  • Protein Engineering, Design & Selection
  • Biotherapeutics: Manufacturing, Chemistry, Analytics and Control
  • Antibody Engineering, Design & Development
  • Cloning, Expressions, Purification & Analytics
  • Protein & Antibody Biotherapeutics

PLUS: 5+ Think Tank Round Table Discussions

Co-located with our highly anticipated 5th Annual Peptides Congress and 5th Biennial Biosimilars & Biobetters Congress

View the Agenda here:

http://bit.ly/2y19vnT

 

Free Pre-Congress Live Webinars

Protein & Antibody Biotherapeutics Manufacturing & Developability Assessment
Tuesday 16th January 2018 | 2pm GMT
David Gervais, Porton Biopharma & Thorsten Lorenz, Novartis 

Register today for free:

http://bit.ly/2yI8hTG

Antibody Biotherapeutics: Current Technologies And Recent Therapeutic Success

Wednesday 24th January 2018 | 3.30pm GMT

David Mantus, Chief Development Officer, Arsanis & Pallavi Tawde, Single B Cell Cloning Platform Leader, Bristol-Myers Squibb

Register today for free:

http://bit.ly/2hRAT2f 

Cant make the dates? Still register and a copy of the webinar recording will be sent to you.

For further information, prices & discounts please contact d.dalby@oxfordglobal.co.uk

phone +44 (0)1865 248455
email info@oxfordglobal.co.uk
web bit.ly/2xvfxQN
email Oxford Global Ltd, Part 1st Floor, Godstow Court, Minns Business Park, Botley, Oxford, OX2 0JB
 
Print this page
Send to a friend
   
spacer
Industry Events

BioTrinity 2018

23-25 April 2018, Novotel London West in Hammersmith

BioTrinity 2018 is taking place from 23-25 April at the Novotel London West in Hammersmith. Now in its 12th year, BioTrinity remains the leading life sciences biopartnering and investment conference in Europe, and is a must attend event for R&D companies, TTOs and academia who are looking to meet, collaborate, partner and seek funding from Big Pharma, Investors and Associated Industry companies.
More info >>

Banner of T3_events_97 on Samedan Banner of ChinaBio_Events_102 on Samedan

White Papers

Value-Added Processing and Quality By Design Principles Help Meet High-Quality Demands

West Pharmaceutical Services, Inc.

The current pharmaceutical market has faced a variety of challenges, including increasing expectations for quality from end-users and regulatory agencies driven by concern for patient safety. While pharmaceutical companies are working to assure that new quality and compliance paradigms are met, a balance must be achieved between the reality of managing costs in an effort to provide a product that meets the requirements of payers along with facilitating profitability in order to continue adequate business reinvestment.
More info >>


News and Press Releases

NDA Group Releases Data Comparing FDA and EMA Ahead of Annual DIA Europe in Basel

Today NDA Group announced their findings from its fifth annual comparison of drug approvals in Europe and the United States, in preparation for this years DIA Europe in Basel, Switzerland. The figures highlight the continued differences between the two regions, and the need for a global approach to drug development to ensure success across both continents.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement